Title : Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB.

Pub. Date : 2013 Mar 15

PMID : 23357978






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-kappaB. Bortezomib tumor protein p53 Homo sapiens